Sepset Biosciences Inc. news
Marking “World Sepsis Day”, The Centre for Drug Research and Development (CDRD) announces the spin-off of a new company, Sepset Biosciences Inc. The company is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier and more targeted treatment of sepsis – a global healthcare problem that is more common than heart attack and claims more lives than any cancer. Infectious disease testing (including sepsis) is one of the fastest grow
Sepsis is the body’s over active and toxic response to an infection that causes hospitalization of more than 18 million people around the world every year, including 30,000 Canadians
- Declared a Global Health Priority by the World Health Organization in 2017
- 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment
Vancouver, Canada: Noting World Sepsis Day, Sepset Biosciences Inc., a spin-out company of The Centre fo
Robert Hancock and Olga Peña—who lost her father to sepsis—may have found a way to diagnose the deadliest syndrome you’ve never heard of.
The doctor suspected 70-year-old Augustin Peña had the flu, so he sent him home to rest and drink lots of fluids. But after three days of continuing to suffer, Peña entered the local hospital in Tolima, Colombia. His entire body became inflamed and swollen, his skin stretched so tightly that his blood was visib
Despite decades of research, therapy for sepsis remains limited to supportive care, including early identification and intervention directed towards elimination of the physical focus of infection (commonly referred to as source control), and appropriate antibiotics. … In this issue of eBioMedicine, Baghela and colleagues present a critical and timely addition to the sepsis endotype literature.